Speaker illustration

Doctor Enrico Giuseppe Ferro

Beth Israel Deaconess Medical Center, Boston (United States of America)

Member of:

European Heart Rythm Association

Dr. Enrico G. Ferro is a cardiology fellow at Beth Israel Deaconess Hospital in Boston, Massachusetts. He graduated magna cum laude from Harvard Medical School, and summa cum laude from Yale College. Dr. Ferro’s interest lies at the intersection of clinical outcomes and health policy, both in the US and abroad. As a research fellow at the Smith Center for Outcomes Research in Cardiology in Boston, he is developing expertise in using nationwide clinical registries, insurance claims database and clinical trials data to evaluate the real-world efficacy of cardiovascular drugs, devices and health policies. At the international level, Dr. Ferro has worked to improve treatment outcomes with teams in Peru, Malaysia, India and Togo. Recently, he has been working with teams in South Africa to address the burden of hypertension and other cardiovascular diseases, and was selected by the World Health Organization to help assemble their list of essential medical devices for cardiovascular care.

Population rates and contemporary outcomes of atrial fibrillation ablation among older adults: a nationwide cohort study

Event: ESC Congress 2023

Topic: Catheter Ablation of Arrhythmias

Session: Adjunctive targets and strategies for atrial fibrillation ablation

Thumbnail

Significant improvement in blood pressure control among older adults with hypertension in rural South Africa: findings from a prospective 5,000-patient cohort, 2014-2019.

Event: ESC Congress 2022

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly 3

Thumbnail

Defining the electrocardiographic and echocardiographic abnormalities in a population of older adults with cardiovascular disease in rural south africa.

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension ePosters

Thumbnail

Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines

Event: ESC Congress 2020

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

ESC 365 is supported by